GW Pharmaceuticals to Report Q2 Financial Results and Host …

LONDON, May 02, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 9 May, 2017 its second quarter financial results for the period ending 31 March, 2017. GW will also host a conference call the same day at 4:30 p.m. EDT. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an

... read more at: http://www.nasdaq.com/press-release/gw-pharmaceuticals-to-report-q2-financial-results--and-host-conference-call-on-9-may-2017-20170502-01096